Literature DB >> 26867654

Serum Antibodies to Glycans in Peripheral Neuropathies.

Sandro Sonnino1, Elena Chiricozzi2, Maria Grazia Ciampa2, Laura Mauri2, Alessandro Prinetti2, Gino Toffano3, Massimo Aureli2.   

Abstract

In peripheral neuropathies, such as sensorimotor neuropathies, motor neuron diseases, or the Guillain-Barré syndrome, serum antibodies recognizing saccharide units, portion of oligosaccharides, or oligosaccharide chains, have been found. These antibodies are called anti-glycosphingolipid (GSL) or anti-ganglioside antibodies. However, the information on the aglycone carrying the hydrophilic oligosaccharide remains elusive. The absolute and unique association of GSL to the onset, development and symptomatology of the peripheral neuropathies could be misleading. Here, we report some thoughts on the matter.

Entities:  

Keywords:  Glycoconjugates; Mimicry; Oligosaccharides; Peripheral neuropathies; Serum antibodies

Mesh:

Substances:

Year:  2016        PMID: 26867654     DOI: 10.1007/s12035-016-9775-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  36 in total

Review 1.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Authors:  Michael P T Lunn; Eduardo Nobile-Orazio
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Françoise Bouhour; Christophe Vial; Lorna Garnier; Nicole Fabien
Journal:  Clin Lab       Date:  2013       Impact factor: 1.138

4.  Cell density regulates crypticity of GM3 ganglioside on human glioma cells.

Authors:  K Tatewaki; T Yamaki; Y Maeda; H Tobioka; H Piao; H Yu; Y Ibayashi; N Sawada; K Hashi
Journal:  Exp Cell Res       Date:  1997-05-25       Impact factor: 3.905

5.  Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.

Authors:  Lan He; Gang Zhang; Weiqiang Liu; Tong Gao; Kazim A Sheikh
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 6.  Gangliosides turnover and neural cells function: a new perspective.

Authors:  G Tettamanti; L Riboni
Journal:  Prog Brain Res       Date:  1994       Impact factor: 2.453

7.  Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.

Authors:  F P Thomas; A M Lee; S N Romas; N Latov
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

Review 8.  Organization of the synthesis of glycolipid oligosaccharides in the Golgi complex.

Authors:  Hugo J F Maccioni; Rodrigo Quiroga; Waldo Spessott
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

9.  Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study.

Authors:  A Prinetti; V Chigorno; G Tettamanti; S Sonnino
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

Review 10.  N-linked protein glycosylation in the ER.

Authors:  Markus Aebi
Journal:  Biochim Biophys Acta       Date:  2013-04-10
View more
  4 in total

1.  Glycosphingolipids.

Authors:  Elena Chiricozzi; Massimo Aureli; Laura Mauri; Erika Di Biase; Giulia Lunghi; Maria Fazzari; Manuela Valsecchi; Emma Veronica Carsana; Nicoletta Loberto; Alessandro Prinetti; Sandro Sonnino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

2.  GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.

Authors:  Erika Di Biase; Giulia Lunghi; Margherita Maggioni; Maria Fazzari; Diego Yuri Pomè; Nicoletta Loberto; Maria Grazia Ciampa; Pamela Fato; Laura Mauri; Emmanuel Sevin; Fabien Gosselet; Sandro Sonnino; Elena Chiricozzi
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

Review 3.  GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.

Authors:  Elena Chiricozzi; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Sandro Sonnino; Laura Mauri
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

4.  Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/- mouse model.

Authors:  Elena Chiricozzi; Laura Mauri; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Margherita Maggioni; Manuela Valsecchi; Simona Prioni; Nicoletta Loberto; Diego Yuri Pomè; Maria Grazia Ciampa; Pamela Fato; Gianluca Verlengia; Stefano Cattaneo; Robert Assini; Gusheng Wu; Samar Alselehdar; Robert W Ledeen; Sandro Sonnino
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.